Compass Therapeutics, Inc.

CMPXNASDAQHealthcare● Active

$2.03

$-0.01(-0.47%)

Market Cap$280776506

P/E Ratio—

52W High$6.88

52W Low$1.61

Avg Volume7.5M

Open$2.04

Beta0.74

Insider Trades Ownership Employees

Compass Therapeutics, Inc.（CMPX）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · CMPX · 截至 2026年6月8日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

2.50

Buy/Sell (by trades)

整体情绪

偏多

↑ Buy 71%仅显示有效交易 · 排除RSU归属29% Sell ↓

Compass Therapeutics, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月8日

CMPX 季度内部人买卖趋势

CMPX 内幕交易卖出 · CMPX 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

7.1M3.6M0

2024 Q1

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 8, 2026

活跃内部人

近12个月交易最活跃 · CMPX CEO内幕交易

显示全部内部人 · 点击卡片过滤下方交易表

▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API

近期内幕交易记录

CMPX 高管卖出股份 · CMPX 董事内幕交易 · SEC Form 4申报

显示最近 37 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
Apr 29, 2026	Anderman Jonathan General Counsel	Award	25,000	$1.89	$47K	196,000	Form 4
Apr 29, 2026	Lerner Neil CAO	Award	15,000	$1.89	$28K	397,500	Form 4
Feb 8, 2026	Schuetz Thomas J. CHIEF EXECUTIVE OFFICER · Director	Other	36,687	$6.52	$239K	6,603,336	Form 4
Jan 9, 2026	Schuetz Thomas J. CHIEF EXECUTIVE OFFICER · Director	Other	46,777	$5.35	$250K	6,640,023	Form 4
Jan 2, 2026	Shin Barry CFO	Award	125,000	$5.17	$646K	525,000	Form 4
Jan 2, 2026	Schuetz Thomas J. CEO · Director	Award	250,000	$5.17	$1.29M⚡	6,686,800	Form 4
Jan 2, 2026	Lerner Neil CAO	Award	62,500	$5.17	$323K	382,500	Form 4
Jan 2, 2026	Anderman Jonathan General Counsel	Award	150,000	$5.17	$776K	171,000	Form 4
Nov 16, 2025	Schuetz Thomas J. CHIEF EXECUTIVE OFFICER · Director	Other	44,025	$4.83	$213K	6,436,800	Form 4
May 27, 2025	Schuetz Thomas J. CHIEF EXECUTIVE OFFICER · Director	Purchase	10,000	$2.11	$21K	6,480,825	Form 4
Apr 9, 2025	GORDON CARL L Director	Sale	3,571,428	$1.59	$5.68M⚡	0	Form 4
Apr 9, 2025	ORBIMED ADVISORS LLC Director	Sale	3,571,428	$1.59	$5.68M⚡	0	Form 4
Apr 7, 2025	Anderman Jonathan Gen Counsel & Corporate Sec	Purchase	20,000	$1.54	$31K	21,000	Form 4
Apr 7, 2025	Lerner Neil CHIEF ACCOUNTING OFFICER	Purchase	20,000	$1.42	$28K	320,000	Form 4
Feb 8, 2025	Schuetz Thomas J. CEO · Director	Other	41,687	$3.50	$146K	6,470,825	Form 4
Jan 9, 2025	Schuetz Thomas J. CEO · Director	Other	58,054	$1.86	$108K	6,512,512	Form 4
Dec 9, 2024	Shin Barry CFO	Award	400,000	$1.65	$660K	400,000	Form 4
Feb 8, 2024	Bisker-Leib Vered CHIEF EXECUTIVE OFFICER · Director	Other	49,198	$1.45	$71K	3,124,426	Form 4
Feb 8, 2024	Schuetz Thomas J. PRESIDENT · Director	Other	44,782	$1.45	$65K	6,570,566	Form 4
Jan 9, 2024	Bisker-Leib Vered CEO · Director	Award	1,753,125	$1.93	$3.38M⚡	3,173,624	Form 4
Jan 9, 2024	Schuetz Thomas J. President of R&D · Director	Award	637,500	$1.93	$1.23M⚡	6,615,348	Form 4
Nov 17, 2023	Bisker-Leib Vered COO	Other	64,415	$1.50	$97K	1,420,499	Form 4
Nov 17, 2023	Schuetz Thomas J. CHIEF EXECUTIVE OFFICER · Director	Other	44,025	$1.50	$66K	5,977,848	Form 4
Mar 10, 2023	Schuetz Thomas J. CHIEF EXECUTIVE OFFICER · Director	Purchase	10,000	$3.37	$34K	6,021,873	Form 4
Feb 27, 2023	Schuetz Thomas J. CHIEF EXECUTIVE OFFICER · Director	Purchase	20,000	$3.98	$80K	6,011,873	Form 4

Anderman Jonathan

General Counsel

Award

日期

Apr 29

股数

25,000

均价

$1.89

总金额

$47K

View Form 4 on SEC.gov

Lerner Neil

CAO

Award

日期

Apr 29

股数

15,000

均价

$1.89

总金额

$28K

View Form 4 on SEC.gov

Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER · Director

Other

日期

Feb 8

股数

36,687

均价

$6.52

总金额

$239K

View Form 4 on SEC.gov

Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER · Director

Other

日期

Jan 9

股数

46,777

均价

$5.35

总金额

$250K

View Form 4 on SEC.gov

Shin Barry

CFO

Award

日期

Jan 2

股数

125,000

均价

$5.17

总金额

$646K

View Form 4 on SEC.gov

Schuetz Thomas J.

CEO · Director

Award

日期

Jan 2

股数

250,000

均价

$5.17

总金额

$1.29M ⚡

View Form 4 on SEC.gov

Lerner Neil

CAO

Award

日期

Jan 2

股数

62,500

均价

$5.17

总金额

$323K

View Form 4 on SEC.gov

Anderman Jonathan

General Counsel

Award

日期

Jan 2

股数

150,000

均价

$5.17

总金额

$776K

View Form 4 on SEC.gov

Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER · Director

Other

日期

Nov 16

股数

44,025

均价

$4.83

总金额

$213K

View Form 4 on SEC.gov

Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER · Director

Purchase

日期

May 27

股数

10,000

均价

$2.11

总金额

$21K

View Form 4 on SEC.gov

GORDON CARL L

Director

Sale

日期

Apr 9

股数

3,571,428

均价

$1.59

总金额

$5.68M ⚡

View Form 4 on SEC.gov

ORBIMED ADVISORS LLC

Director

Sale

日期

Apr 9

股数

3,571,428

均价

$1.59

总金额

$5.68M ⚡

View Form 4 on SEC.gov

Anderman Jonathan

Gen Counsel & Corporate Sec

Purchase

日期

Apr 7

股数

20,000

均价

$1.54

总金额

$31K

View Form 4 on SEC.gov

Lerner Neil

CHIEF ACCOUNTING OFFICER

Purchase

日期

Apr 7

股数

20,000

均价

$1.42

总金额

$28K

View Form 4 on SEC.gov

Schuetz Thomas J.

CEO · Director

Other

日期

Feb 8

股数

41,687

均价

$3.50

总金额

$146K

View Form 4 on SEC.gov

Schuetz Thomas J.

CEO · Director

Other

日期

Jan 9

股数

58,054

均价

$1.86

总金额

$108K

View Form 4 on SEC.gov

Shin Barry

CFO

Award

日期

Dec 9

股数

400,000

均价

$1.65

总金额

$660K

View Form 4 on SEC.gov

Bisker-Leib Vered

CHIEF EXECUTIVE OFFICER · Director

Other

日期

Feb 8

股数

49,198

均价

$1.45

总金额

$71K

View Form 4 on SEC.gov

Schuetz Thomas J.

PRESIDENT · Director

Other

日期

Feb 8

股数

44,782

均价

$1.45

总金额

$65K

View Form 4 on SEC.gov

Bisker-Leib Vered

CEO · Director

Award

日期

Jan 9

股数

1,753,125

均价

$1.93

总金额

$3.38M ⚡

View Form 4 on SEC.gov

Schuetz Thomas J.

President of R&D · Director

Award

日期

Jan 9

股数

637,500

均价

$1.93

总金额

$1.23M ⚡

View Form 4 on SEC.gov

Bisker-Leib Vered

COO

Other

日期

Nov 17

股数

64,415

均价

$1.50

总金额

$97K

View Form 4 on SEC.gov

Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER · Director

Other

日期

Nov 17

股数

44,025

均价

$1.50

总金额

$66K

View Form 4 on SEC.gov

Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER · Director

Purchase

日期

Mar 10

股数

10,000

均价

$3.37

总金额

$34K

View Form 4 on SEC.gov

Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER · Director

Purchase

日期

Feb 27

股数

20,000

均价

$3.98

总金额

$80K

View Form 4 on SEC.gov

⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股

1 / 2

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 CMPX 内幕交易

CMPX 内幕交易

Compass Therapeutics, Inc.（CMPX）内幕交易数据来源于公司内部人（包括Schuetz Thomas J. (CHIEF EXECUTIVE OFFICER · Director), Anderman Jonathan (General Counsel), Lerner Neil (CAO)）提交的SEC Form 4申报文件。过去12个月内，4位内部人向SEC提交了交易申报。CMPX内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看Compass Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

CMPX 内幕交易 · 5个问题

Compass Therapeutics, Inc.（CMPX）的内部人包括高管和董事，如Schuetz Thomas J. (CHIEF EXECUTIVE OFFICER · Director), Anderman Jonathan (General Counsel), Lerner Neil (CAO)等。过去12个月内，4位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

CMPX 董事内幕交易CMPX 内部人名单Compass Therapeutics, Inc. 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026